(Q44367500)

2 December 2017

title

Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation (English)

1 reference

2 December 2017

1 reference

Elias David-Neto

1

1 reference

2 December 2017

Lilian Monteiro Pereira Araujo

2

1 reference

2 December 2017

Nairo Massakazu Sumita

3

1 reference

2 December 2017

Maria Elizabeth Mendes

4

1 reference

2 December 2017

Maria Cristina Ribeiro Castro

5

1 reference

2 December 2017

Cristiane Feres Alves

6

1 reference

2 December 2017

Erica Kakehashi

7

1 reference

2 December 2017

Paschoalina Romano

8

1 reference

2 December 2017

Elisa Midori Yagyu

9

1 reference

2 December 2017

Margaret Queiroga

10

1 reference

2 December 2017

William Carlos Nahas

11

1 reference

2 December 2017

Luiz Estevam Ianhez

12

1 reference

2 December 2017

publication date

22 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

18

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

266-272

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-002-1057-1

2 December 2017

exact match

0 references

cites work

Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children

1 reference

12 December 2020

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Reci

1 reference

12 December 2020

Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation

1 reference

12 December 2020

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

1 reference

12 December 2020

Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.

1 reference

12 December 2020

A novel approach to the treatment of chronic allograft nephropathy

1 reference

12 December 2020

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

12 December 2020

Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.

1 reference

12 December 2020

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

1 reference

12 December 2020

A strategy to calculate cyclosporin A area under the time-concentration curve in pediatric renal transplantation

1 reference

12 December 2020

The use of mycophenolate mofetil suspension in pediatric renal allograft recipients

1 reference

12 December 2020

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

1 reference

12 December 2020

Comparing methods of measurement: why plotting difference against standard method is misleading.

1 reference

12 December 2020

The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.

1 reference

12 December 2020

Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients

1 reference

12 December 2020

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

12 December 2020

The emerging role of gene polymorphisms determining outcome after solid-organ transplantation

1 reference

12 December 2020

Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.

1 reference

12 December 2020

Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients

1 reference

12 December 2020

Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.

1 reference

12 December 2020

Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability

1 reference

12 December 2020

Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy

1 reference

12 December 2020

Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation

1 reference

12 December 2020

Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection

1 reference

12 December 2020

Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation

1 reference

12 December 2020

Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation

1 reference

12 December 2020

New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine

1 reference

12 December 2020

Immunosuppression and cancer: the ciclosporin case

1 reference

12 December 2020

Cyclosporin A monitoring and AUC determination--where do we go?

1 reference

12 December 2020

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

12 December 2020

10.1007/S00467-002-1057-1

Identifiers

DOI

0 references

1 reference